Acumen Pharmaceuticals, Inc.
ABOS
$1.98
$0.052.59%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -11.69% | -3.87% | -13.06% | -14.37% | -23.08% |
| Total Receivables | 27.76% | -20.51% | 12.58% | 96.87% | 200.94% |
| Inventory | -- | -- | -- | 11.19% | 18.18% |
| Prepaid Expenses | 315.98% | -64.86% | -43.94% | -15.13% | 964.21% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -4.21% | -6.66% | -9.66% | -12.24% | -4.98% |
| Total Current Assets | -10.95% | -4.22% | -13.10% | -14.12% | -22.21% |
|
|
|||||
| Total Current Assets | -10.95% | -4.22% | -13.10% | -14.12% | -22.21% |
| Net Property, Plant & Equipment | -14.03% | -10.19% | 10.03% | -11.95% | -10.47% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -6.65% | -0.55% | -4.22% | -6.65% | -14.71% |
| Total Assets | -17.26% | -15.93% | -14.44% | -10.48% | -7.59% |
|
|
|||||
| Total Accounts Payable | -67.57% | 99.15% | -81.30% | 141.16% | -44.38% |
| Total Accrued Expenses | -23.50% | 26.84% | -18.03% | 25.25% | 58.45% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2,536.62% | 2.90% | 3.76% | 3.10% | 3.20% |
| Total Finance Division Other Current Liabilities | 118.63% | -61.48% | 81.74% | 14.43% | 34.90% |
| Total Other Current Liabilities | 118.63% | -61.48% | 81.74% | 14.43% | 34.90% |
| Total Current Liabilities | -11.68% | 28.71% | -30.04% | 38.63% | 29.59% |
|
|
|||||
| Total Current Liabilities | -11.68% | 28.71% | -30.04% | 38.63% | 29.59% |
| Long-Term Debt | -9.47% | 1.20% | 0.37% | -0.86% | 1.00% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -49.35% | -32.46% | -24.00% | -18.92% | -15.53% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -10.53% | 11.98% | -14.37% | 14.87% | 10.69% |
|
|
|||||
| Common Stock & APIC | 0.48% | 0.49% | 0.48% | 0.46% | 0.47% |
| Retained Earnings | -6.70% | -11.57% | -8.86% | -12.90% | -11.53% |
| Treasury Stock & Other | 373.91% | 53.33% | 131.25% | -109.27% | 415.85% |
| Total Common Equity | -20.42% | -24.72% | -14.46% | -16.29% | -10.96% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -20.42% | -24.72% | -14.46% | -16.29% | -10.96% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -20.42% | -24.72% | -14.46% | -16.29% | -10.96% |
|
|
|||||